By
AmyT on
November 3, 2010
Why is affordable generic insulin not available to patients in the US? Mainly because the big manufacturers have a stronghold on the patents for this complicated “biologic” drug. But now it seems Big Pharma itself may be presenting a nice alternative.
What I’m talking about is Pfizer’s new attempt to enter the injectable insulin market (less risky than their Exubera flop!) Pfizer and Biocon, a biopharmaceutical company in India, recently announced a multimillion dollar partnership…
Read more »
By
AmyT on
October 8, 2010
Personally, I feel that mail-order prescription services have saved my life, so I almost choked on my breakfast bar the other morning reading this Philadelphia Inquirer headliner: “Pharmacists Take On Mail Order.”
You. Are. Kidding. Me. Now the powers that be are trying to take away the ability for us to have 90-days’ supply of our meds and equipment delivered to our doorstep? Don’t they know what a boon that is to people who depend…
Read more »
By
AmyT on
August 31, 2010
According to Innovation.org, the Pharmaceutical Research and Manufacturers of America (PhRMA) has a new report out on diabetes, which states:
“A record 235 new medicines to treat diabetes, one of the fastest-growing diseases in America, are being developed by America’s pharmaceutical research and biotechnology companies.”
Wow. Do we really need that many new medicines? What about innovations in the devices and technology that help us manage better? And I can’t help wondering, in all of…
Read more »
By
AmyT on
August 23, 2010
My Spring post on the new injectable type 2 diabetes drug Victoza is in the running for one of the most-commented-ever blog posts here at the ‘Mine. Over 100 people now taking the medication have chimed in.
Victoza, for the unfamiliar, is a new once-daily form of the new-generation GLP-1 drugs that stimulate pancreas cells to release insulin in people with type 2 diabetes. It’s a head-to-head competitor with the injectable drug Byetta, and both…
Read more »
Get ready for a slew of diabetes news announcements, because the ADA’s huge annual conference starts today!
I’ll be on an airplane pretty much all day (Friday) heading out to Orlando to cover this conference live, although I must warn you: it’s quite overwhelming. Running around the 450,000 square-foot convention center trying to see every diabetes company represented in the enormous exhibit halls while hundreds of symposia and other talk sessions are happening simultaneously is…
Read more »
